Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05711056 · ClinicalTrials.gov registry record · NA
Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment
A NA study of Opioid Use and Opioid Abuse, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 480
- Enrollment target
- 1
- Study location
NCT05711056: Recruiting NA study of Opioid Use and Opioid Abuse, sponsored by Emory University.
NCT05711056 is a NA study of Opioid Use and Opioid Abuse that is actively recruiting participants, run by Emory University. The registered enrollment target is 480 participants, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05711056, a NA study of Opioid Use and Opioid Abuse, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 480 participants
- Enrollment target
- 1
- Study location
Study Summary
The overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment. The investigators will implement a novel collaboration between rural EDs, medical toxicologists at the Georgia Poison Center (GPC), peer recovery coaches (PRCs) and RCOs throughout Georgia to bridge the gap between OUD treatment need in rural EDs and specialty physician availability at the GPC. Research activities will be conducted during two broad phases, at three rural EDs in Georgia: planning and implementation. During the planning phase, aggregate data will be obtained to determine each ED's existing practices treating patients with OUD and opioid withdrawal. During the implementation phase, the researchers will prospectively study a poison center OUD consultation and PRC intervention as it is rolled out at each site, collecting participant-level data. Sites will be rolled into the implementation phase in a stepped-wedge fashion, so there will be times when some sites are in the planning phase while others are in the implementation phase.
Primary Outcome
Change in number of patients who present with acute opioid withdrawal, acute opioid overdose, or requesting treatment for OUD will be collected
Conditions Studied
Interventions
- BEHAVIORAL Sociobehavioral Intervention
Study Locations (1)
Georgia
- Georgia Poison Center - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 480 participants |
| Start Date | 2023-08-30 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT05711056 shows while recruiting
NCT05711056 is an interventional study that assigns participants to a tested intervention. The registered 480 participants enrollment target is mid-sized for trials with a published cap, below the 148,255-participant average among 105 other Opioid Use trials with a reported enrollment target (100% lower).
The record links to 2 conditions, with Opioid Use appearing as the primary indexed condition, and to 1 intervention - of which Sociobehavioral Intervention is the first listed.
NCT05711056 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT05711056 about?
NCT05711056 is a clinical study titled "Rural Expanded Access to OUD Care & Linkage Using Toxicologists for Telehealth Initiated Treatment". The overarching goal of this project is to increase the availability of OUD treatment in rural counties in the state of Georgia by using Emergency Department (ED)-based telehealth strategies to initiate MOUD and connect patients to treatment. The investigators will implement a novel collaboration b...
What is the current status of trial NCT05711056?
This trial is currently recruiting. It is a NA study. The enrollment target is 480 participants. The study started on 2023-08-30. Estimated completion is 2026-08.
What conditions does trial NCT05711056 study?
This clinical trial studies the following conditions: Opioid Use, Opioid Abuse.
What interventions are being tested in trial NCT05711056?
The interventions under investigation include: Sociobehavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05711056?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05711056 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05711056's enrollment target sits among peer trials
480 21st of 105 higher than 85 of 105 other Opioid Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
QL vs LAI for Palatoplasty
RECRUITING · NA
-
Machine-Learning Prediction and Reducing Overdoses With EHR Nudges
RECRUITING · NA
-
Hip Arthroscopy Postoperative Opioid Demands
RECRUITING · NA
-
Neuroimaging of Opioid Phase (OPAL)
RECRUITING · NA
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Opioid Prescribing Practices in Laparoscopic Gynecologic Surgery
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01954992 · 480 participants · Phase 3
Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer
- NCT03023696 · 480 participants · NA
Can Prophylactic Foraminotomy Prevent C5 Palsy
- NCT04948060 · 480 participants · NA
Tribally Engaged Approaches to Lung Screening (TEALS)
- NCT05053230 · 480 participants · NA
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI